Anika Therapeutics (ANIK) Goodwill & Intangibles (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Goodwill & Intangibles of $9.5 million for Q2 2026, down 59.97% year-over-year from $23.8 million in Q2 2025, and down 0.7% quarter-over-quarter from $9.6 million in Q1 2026.
Anika Therapeutics (ANIK) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Goodwill & Intangibles for 17 consecutive years, with $9.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Goodwill & Intangibles fell 59.97% year-over-year to $9.5 million; the TTM figure through Jun 2026 stood at $9.5 million (down 59.97% YoY), while the FY2025 annual figure was $9.8 million, up 26.27% from the prior year.
- Goodwill & Intangibles retreated to $9.5 million in Q2 2026 per ANIK's latest filing, from $9.6 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $119.8 million in Q1 2022 and bottomed at $7.7 million in Q4 2024.
- Historically, Goodwill & Intangibles has averaged $62.7 million across 5 years, with a median of $57.3 million in 2024.
- On a YoY basis, Goodwill & Intangibles climbed as much as 26.27% in 2025 and fell as far as 84.09% in 2025.
- Anika Therapeutics' Goodwill & Intangibles stood at $119.5 million in 2022, then plunged by 77.06% to $27.4 million in 2023, then sank by 71.81% to $7.7 million in 2024, then rose by 26.27% to $9.8 million in 2025, then retreated by 2.35% to $9.5 million in 2026.
- Business Quant data shows ANIK's Goodwill & Intangibles at $9.5 million in Q2 2026, $9.6 million in Q1 2026, and $9.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Anika Therapeutics | 286.46 Mn | 248.05 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.53 Mn |
| Mar 31, 2026 | 9.59 Mn |
| Dec 31, 2025 | 9.75 Mn |
| Sep 30, 2025 | 23.79 Mn |
| Jun 30, 2025 | 23.79 Mn |
| Mar 31, 2025 | 9.12 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 57.60 Mn |
| Jun 30, 2024 | 57.30 Mn |
| Mar 31, 2024 | 57.35 Mn |
| Dec 31, 2023 | 27.41 Mn |
| Sep 30, 2023 | 119.39 Mn |
| Jun 30, 2023 | 119.60 Mn |
| Mar 31, 2023 | 119.60 Mn |
| Dec 31, 2022 | 119.48 Mn |
| Sep 30, 2022 | 118.86 Mn |
| Jun 30, 2022 | 119.31 Mn |
| Mar 31, 2022 | 119.76 Mn |
| Dec 31, 2021 | 120.52 Mn |
| Sep 30, 2021 | 120.69 Mn |